BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21334267)

  • 21. [Report of a case of glucagonoma misdiagnosed as "eczema" and "hepatic angioma" for three years and review of literature].
    Dai W; Shi Y; Cai L
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):190-2. PubMed ID: 7648942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Facial erythema and pancreatic glucagonoma].
    Erce C; Morales DJ; Diego L; Mazorra F; García de Polavieja M
    Rev Esp Enferm Dig; 1997 Feb; 89(2):137-8. PubMed ID: 9115822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome.
    Virani S; Prajapati V; Devani A; Mahmood MN; Elliott JF
    J Am Acad Dermatol; 2013 Feb; 68(2):e44-6. PubMed ID: 23317985
    [No Abstract]   [Full Text] [Related]  

  • 24. Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration.
    Santangelo WC; Unger RH; Orci L; Dueno MI; Popma JJ; Krejs GJ
    Pancreas; 1986; 1(5):464-9. PubMed ID: 2882503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed diagnosis of glucagonoma syndrome: a case report.
    Huo J; Liu P; Chen X; Wu J; An J; Ren J
    Int J Dermatol; 2016 Nov; 55(11):1272-1274. PubMed ID: 26679842
    [No Abstract]   [Full Text] [Related]  

  • 26. Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report.
    Cao X; Wang X; Lu Y; Zhao B; Shi J; Guan Q; Zhang X
    Medicine (Baltimore); 2019 Sep; 98(38):e17037. PubMed ID: 31567941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagonoma syndrome and necrolytic migratory erythema.
    Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
    Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
    Kitoh M; Ohyama K; Shigeo ; Arao AT
    Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
    [No Abstract]   [Full Text] [Related]  

  • 29. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
    Tolliver S; Graham J; Kaffenberger BH
    Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
    Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
    [No Abstract]   [Full Text] [Related]  

  • 32. Glucagonoma and necrolytic migratory erythema.
    Echenique-Elizondo M; Martínez de Lizarduy I
    Rev Esp Enferm Dig; 2005 Jun; 97(6):455-7. PubMed ID: 16011420
    [No Abstract]   [Full Text] [Related]  

  • 33. Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?
    Manes G; Pellegrini A; Riccardi F; Uomo G
    Ital J Gastroenterol; 1995 Jun; 27(5):248-9. PubMed ID: 8541575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The glucagonomas (author's transl)].
    Luyckx AS; Lefebvre PJ
    Diabete Metab; 1981 Dec; 7(4):289-300. PubMed ID: 6120860
    [No Abstract]   [Full Text] [Related]  

  • 35. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
    Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
    Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
    [No Abstract]   [Full Text] [Related]  

  • 36. Necrolytic migratory erythema associated with alteration from predominantly gastrin-secreting to predominantly glucagon-secreting pancreatic neuroendocrine tumor.
    Kido-Nakahara M; Nakahara T; Miki M; Igarashi H; Ito T; Furue M
    Eur J Dermatol; 2014; 24(6):702-3. PubMed ID: 25333507
    [No Abstract]   [Full Text] [Related]  

  • 37. [Necrolytic migratory erythema in a patient with a glucagonoma].
    Demirbas M; Prens B
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of glucagonoma: report of one case].
    Cheng H; Chen M; Yang G
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):618-insidebackcover. PubMed ID: 23644134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema.
    Feldmann R; Wahl S; Steiner A
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e306-e307. PubMed ID: 29419911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.